Phytosterols for dyslipidemia

American Journal of Health-System Pharmacy

Volumn 67, Issue 14, 2010, Pages 1165-1173

  Malinowski, Jennifer M ^a,b   Gehret, Monica M ^c  

^a WILKES UNIVERSITY   (United States)

^b Geisinger Lake Scranton   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dosage; Drug interactions; Hypercholesterolemia; Phytosterols; Toxicity

Indexed keywords

BILE ACID SEQUESTRANT; CERIVASTATIN; COLESTYRAMINE; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MARGARINE; OLIVE OIL; PHYTOSTEROL; PLACEBO; SITOSTANOL; YOGHURT; ANTILIPEMIC AGENT;

APPETITE DISORDER; CONSTIPATION; DIARRHEA; DIET SUPPLEMENTATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DYSLIPIDEMIA; DYSPEPSIA; FECES COLOR; FLATULENCE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERCHOLESTEROLEMIA; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OLIVE; ORANGE JUICE; PREGNANCY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TABLET; ADULT; ANIMAL; BLOOD; CHILD; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; HERB DRUG INTERACTION; PATHOPHYSIOLOGY;

ADULT; ANIMALS; ANTILIPEMIC AGENTS; CHILD; CHOLESTEROL, LDL; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSLIPIDEMIAS; HERB-DRUG INTERACTIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PHYTOSTEROLS;

EID: 77957680453     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp090427     Document Type: Review

References (78)

1. National Heart, Lung, and Blood Institute. Third report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): executive summary. www.nhlbi.nih.gov/guidelines/ cholesterol/atp3xsum.pdf (accessed 2009 Jul 31).
2. Grundy SM, Cleeman JI, Bairey Merz CN et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. www.nhlbi.nih.gov/guidelines/cholesterol/atp3upd04.htm (accessed 2009 Jul 31).
3. McKenney J, Davidson M, Jacobson T et al. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol. 2006; 97(suppl):89C-94C.
4. Lichtenstein A, Deckelbaum R. Stanol/ sterol ester containing foods and blood cholesterol levels: a statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation. 2001; 103:1177-9.
5. Mietinnen T, Gylling H. Plant stanol and sterol esters in prevention of cardiovascular diseases. Ann Med. 2004; 36:126-34. (Pubitemid 38510018)
6. Devaraj S, Jialal I. The role of dietary supplementation with plant sterols and stanols in the prevention of cardiovascular disease. Nutr Rev. 2006; 64:348-54. (Pubitemid 44124979)
7. O'Neill FH, Sanders TA, Thompson GR. Comparison of efficacy of plant stanol ester and sterol ester: short-term and longer-term studies. Am J Cardiol. 2005; 96(suppl):29D-36D.
8. Thompson GR, Grundy SM. History and development of plant sterol and stanol esters for cholesterol-lowering purposes. Am J Cardiol. 2005; 96(suppl):3D-9D.
9. Lees RS, Lees AM. Effects of sitosterol therapy on plasma lipid and lipoprotein concentrations. In: Greten H, ed. Lipoprotein metabolism. Berlin: Springer-Verlag; 1976:119-24.
10. Wester I. Dose responsiveness to plant stanol esters. Eur Heart J Suppl. 1999; 1:S104-8.
11. Ostlund RE Jr, Spilburg CA, Stenson WF. Sitostanol administered in lecithin micelles potently reduces cholesterol absorption in humans. Am J Clin Nutr. 1999; 70:826-31. (Pubitemid 29512907)
12. Nessinen M, Gylling H, Vuoristo M et al. Micellar distribution of cholesterol and phytosterols after duodenal plant stanol ester infusion. Am J Physiol Gastrointest Liver Physiol. 2002; 282:G1009-15.
13. Salo P, Wester I. Low-fat formulations of plant stanols and sterols. Am J Cardiol. 2005; 96(suppl):51D-54D.
14. Plat J, Mensink RP. Increased intestinal ABCA1 expression contributes to the decrease in cholesterol absorption after plant stanol consumption. FASEB J. 2002; 16:1248-53. (Pubitemid 34815413)
15. Yu L, Hawkins J, Berge KE et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest. 2002; 100:671-80. (Pubitemid 34988791)
16. Miettinen TA. Cholesterol absorption inhibition: a strategy for cholesterol-lowering therapy. Int J Clin Pract. 2001; 55:710-6. (Pubitemid 34023837)
17. Chen JT, Wesley R, Shamburek RD et al. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy. 2005; 25:171-83. (Pubitemid 40223479)
18. Katan MB, Grundy SM, Jones P et al. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc. 2003; 78:965-78.
19. Miettinen TA, Puska P, Gylling H et al. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med. 1995; 333:1308-12.
20. Thompson GR. Additive effects of plant sterol and stanol esters to statin therapy. Am J Cardiol. 2005; 96(suppl):37D-39D.
21. Plat J, Brufau G, Dallinga-Thie GM. A plant stanol yogurt drink alone or combined with low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. J Nutr. 2009; 139:1143-9.
22. Moghadasian MH, Frohlich JJ. Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: clinical and experimental evidence. Am J Med. 1999; 107:588-94.
23. Ketomaki A, Gylling H, Miettinen T. Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject. J Lab Clin Med. 2004; 143:255-62. (Pubitemid 38510121)
24. Hallikainen MA, Sarkkinen ES, Gylling H et al. Comparison of the effects of plant sterol ester and plant stanol esterenriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr. 2000; 54:715-25.
25. Weststrate JA, Meijer GW. Plant sterolenriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr. 1998; 52:334-43. (Pubitemid 28230699)
26. Jones PJ, Vanstone CA, Sarjaz MR et al. Phytosterols in low and non-fat beverages as part of a controlled diet fail to lower plasma lipid levels. J Lipid Res. 2003; 44:713-9.
27. Clifton PM, Noakes M, Sullivan D et al. Cholesterol lowering effects of plant sterol esters differ in milk, yogurt, bread and cereal. Eur J Clin Nutr. 2004; 58:503-9. (Pubitemid 38443712)
28. Moghadasian MH, McManus BM, Pritchard PH et al. "Tall oil"-derived phytosterols reduce atherosclerosis in ApoE deficient mice. Arterioscler Thromb Vasc Biol. 1997; 17:119-26.
29. Volger OL, Mensink RP, Plat J et al. Dietary vegetable oil and wood derived plant stanol esters reduce atherosclerotic lesion size and severity in apo E 3-Leiden transgenic mice. Atherosclerosis. 2001; 157:375-81. (Pubitemid 32710016)
30. Moghadasian MH, Godin DV, McManus BM et al. Lack of regression of atherosclerotic lesions in phytosterol treated apo E deficient mice. Life Sci. 1999; 64:1029-36. (Pubitemid 29130561)
31. Jenkins DJ, Kendall CC, Marchie A et al. Effects of a dietary portfolio of cholesterollowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA. 2003; 290:502-10. (Pubitemid 37430504)
32. Cater NB, Garcia AB, Vega GL et al. Responsiveness of plasma lipids and lipoproteins to plant stanol esters. Am J Cardiol. 2005; 96:23D-28D.
33. De Jong A, Plat J, Bast A et al. Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment. Eur J Clin Nutr. 2008; 62:263-73. (Pubitemid 351234262)
34. Mensink R, Ebbing S, Lindhout M et al. Effect of plant stanol esters in low fat yoghurt on serum lipids, lipoproteins, noncholesterol sterols and fat soluble antioxidant concentrations. Atherosclerosis. 2002; 100:205-13. (Pubitemid 34076656)
35. Miettinen TA, Strandberg T, Gylling H; for the Finnish Investigators of the Scandinavian Simvastatin Survival Study Group. Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients. Arterioscler Thromb Vasc Biol. 2000; 20:1340-6.
36. Blair SN, Capuzzi DM, Gottlieb SO et al. Incremental reduction of serum total cholesterol and LDL-C with the addition of plant stanol-ester containing spread to statin therapy. Am J Cardiol. 2000; 86:46-52. (Pubitemid 30365142)
37. Neil HA, Meijer GW, Roe LS. Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spread. Atherosclerosis. 2001; 156:327-9.
38. Simons LA. Additive effect of plant sterol ester margarine and cerivastatin in lowering LDL-C in primary hypercholesterolemia. Am J Cardiol. 2002; 90:737-40. (Pubitemid 35279393)
39. O'Neill FH, Brynes A, Mandeno R et al. Comparison of effects of dietary plant sterol and stanol esters on lipid metabolism. Nutr Metab Cardiovasc Dis. 2004; 14:133-42. (Pubitemid 39090776)
40. Castro Cabezas M, de Vries JH, Van Oostrom AJ et al. Effects of a stanolenriched diet on plasma cholesterol and triglycerides in patients treated with statins. J Am Diet Assoc. 2006; 106:1564-9. (Pubitemid 44415592)
41. Goldberg AC, Ostlund RE, Bateman JH. Effect of plant stanol tablets on lowdensity lipoprotein cholesterol lowering in patients on statin drugs. Am J Cardiol. 2006; 97:376-9. (Pubitemid 43133053)
42. De Jong A, Plat J, Lutjohann D et al. Effects of long term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment. Br J Nutr. 2008; 100:937-41.
43. Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol. 1998; 81:582-7. [Erratum, Am J Cardiol. 1998; 82:128.]
44. Gylling H, Miettinen TA. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects. Nutr Metab Cardiovasc Dis. 2002; 12:19-23. (Pubitemid 135712743)
45. Nigon F, Serfaty C, Beucler I et al. Plant sterol enriched margarine lowers plasma LDL in hyperlipidemic subjects with low cholesterol intake: effect of fibrate treatment. Clin Chem Lab Med. 2001; 39:634-40. (Pubitemid 32725751)
46. Jakulj L, Trip MD, Sudhop T et al. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels. J Lipid Res. 2005; 46:2692-8. (Pubitemid 43107481)
47. Gylling H, Miettinen TA. Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolemic NIDDM patients before and during sitostanol ester margarine treatment. Diabetologia. 1994; 37:773-80.
48. Zaiken K, Raval KD. Treatment of hypercholesterolemia in pregnancy: risks versus benefits. J Pharm Technol. 2005; 21:258-61.
49. Latinen K, Isolauri E, Kaipiainen L et al. Plant stanol ester spreads as components of a balanced diet for pregnant and breast-feeding women: evaluation of clinical safety. Br J Nutr. 2009; 101:1797-804.
50. Becker M, Staab D, Von Bergmann K. Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol. J Pediatr. 1993; 122:292-6. (Pubitemid 23041564)
51. Williams CL, Bollella MC, Strobino B et al. Plant stanol ester and bran fiber in childhood: effects of lipids, stool weight, and stool frequency in preschool children. J Am Coll Nutr. 1999; 18:572-81. (Pubitemid 30010737)
52. Tammi A, Ronnemaa T, Gylling H et al. Plant stanol ester margarine lowers serum total and low density lipoprotein cholesterol concentrations of healthy children: the STRIP project. J Pediatr. 2000; 136:503-10. (Pubitemid 30469592)
53. McCrindle BW, Urbina EM, Dennison BA et al. Drug therapy of high-risk lipid abnormalities in children and adolescents. Circulation. 2007; 115:1948-67.
54. Gylling H, Siimes M, Miettinen TA. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia. J Lipid Res. 1995; 36:1807-12.
55. Bhattacharya S. Therapy and clinical trials: plant sterols and stanols in management of hypercholesterolemia: where are we now? Curr Opin Lipidol. 2006; 17:98-100.
56. Nguyen TT. Reducing cholesterol with plant stanol esters. Sci Med. 2002; 8(1):28-35.
57. McPherson TB, Ostlund RE, Goldberg AC et al. Phytostanol tablets reduce human LDL-cholesterol. J Pharm Pharmacol. 2005; 57:889-96. (Pubitemid 40873939)
58. Plat J, Mensink RP. Plant stanol and sterol esters in the control of blood cholesterol levels: mechanism and safety aspects. Am J Cardiol. 2005; 96(suppl):15D-22D.
59. Grundy SM. Stanol esters as a component of maximal dietary therapy in the National Cholesterol Education Program Adult Treatment Panel III report. Am J Cardiol. 2005; 96(suppl):47D-50D.
60. Plat J, van Onselen RN, van Heugten M et al. Effects on serum lipids, lipoproteins, and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Eur J Clin Nutr. 2000; 54:671-7.
61. Noakes M, Clifton P, Ntanios F et al. An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentration. Am J Clin Nutr. 2002; 75:79-86. (Pubitemid 34008024)
62. Raeini-Sajarz M, Ntanios FY, Vanstone CA et al. No changes in serum fat-soluble vitamin and carotenoid concentrations with the intake of plant sterol/stanol esters in the context of a controlled diet. Metabolism. 2002; 51:652-6. (Pubitemid 34516523)
63. Law M. Plant sterol and stanol margarines and health. BMJ. 2001; 320:861-4.
64. Richelle M, Ensien M, Hager C et al. Both free and esterified plant sterols reduce cholesterol absorption and bioavailability of beta carotene and alpha tocopherol in normocholesterolemic subjects. Am J Clin Nutr. 2004; 80:171-7. (Pubitemid 41115571)
65. Jansen PJ, Lütjohann D, Abildayeva K et al. Dietary plant sterols accumulate in the brain. Biochim Biophys Acta. 2006; 1761:445-53. (Pubitemid 43776461)
66. Schiepers OJ, DeGroot RH, vanBoxtel M et al. Consuming functional foods enriched with plant stanol or sterol esters for 85 weeks does not affect neurocognitive functioning or mood in statin treated hypercholesterolemic individuals. J Nutr. 2009; 139:1360-73.
67. De Jong A, Plat J, Mensink RP. Plant sterol or stanol consumption does not change osmotic fragility of the enterocyte. Atherosclerosis. 2004; 5:115s. Abstract.
68. Kozlowska-Wojciechowska M, Jastrzebska M, Naruszewicz M et al. Impact of margarine enriched with plant sterols on blood lipids, platelet function, and fi- brinogen level in young men. Metabolism. 2003; 52:1373-8. (Pubitemid 37461102)
69. Miettinen TA, Gylling H. Effect of statins on noncholesterol sterol levels: implications for use of plant stanols and sterols. Am J Cardiol. 2005; 96(suppl):40D-46D.
70. Sudhop T, Gottwald BM, von Bergmann K. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism. 2002; 51:1519-21. (Pubitemid 36018822)
71. Fassbender K, Lutjohann D, Dik MG et al. Moderately elevated plant sterol levels are associated with reduced cardiovascular risk-the LASA study. Atherosclerosis. 2008; 196:283-8.
72. Salen G, Patel S, Batta AK. Sitosterolemia. Cardiovasc Drug Rev. 2002; 20:255-70.
73. Ostlund RE Jr, McGill JB, Zeng CM et al. Gastrointestinal absorption and plasma kinetics of soy-phytosterols and phytostanols in humans. Am J Physiol Endocrinol Metab. 2002; 282:E911-6.
74. Burck PJ, Thakkar AL, Zimmerman RE. Antifertility action of a sterol sulphate in the rabbit. J Reprod Fertil. 1982; 66:109-12. (Pubitemid 13247992)
75. Ling WH, Jones PJ. Dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci. 1995; 57:195-206.
76. Plat J, Mensink RP. Vegetable oil based versus wood based stanol ester mixtures: effects on serum lipids and hemostatic factors in non- hypercholesterolemic subjects. Atherosclerosis. 2000; 148:101-12.
77. Nguyen T, Dale L. Plant stanol esters and vitamin K. Mayo Clin Proc. 1999; 74:642-3. Letter.
78. Electronic Code of Federal Regulations. Title 21, subsection 101.83: health claims: plant sterol/stanol esters and risk of coronary heart disease (CHD). http://ecfr. gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&rgn= div8&view=text&node=21:2.0.1. 1.2.5.1.14&idno=21 (accessed 2010 Mar 18).